BriaCell Therapeutics Corp.
BCTX · Healthcare · $36M
After-hours $4.18+2.42%
Price
$3.47
$4.08
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
7/'26
Revenue$2M
4/'26 vs prev quarter
Company Health
Market Cap$36M
Cash on Hand$23M62.7% of market cap
Free Cash Flow$-37M-102.0% of market cap
Among 463 Biotechnology peers
LowMedianHigh
PBR1.5xmedian 2.0xROE-154.1%median -54.5%BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer CenterSep 8
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™Aug 24
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate CancerAug 5
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast CancerJul 16
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™Jul 15
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™Jul 7
